Gastric Band
ProcedureSurgical intervention in which a band is inserted around the top of the stomach to reduce its size.
NCT Number: NCT02841527
Obesity is an increasing health problem in the United Kingdom (UK) and is predicted to worsen.
In the UK and worldwide the three most commonly performed operations are laparoscopic adjustable gastric banding ('BAND surgery'), laparoscopic gastric bypass ('BYPASS') and laparoscopic sleeve gastrectomy ('SLEEVE'). All lead to weight loss, but they are associated with different problems. This study (BYBANDSLEEVE) is a randomised trial with a target recruitment of 1341 patients in twelve hospitals and its aim is to compare the effectiveness, cost effectiveness and acceptability of BAND, BYPASS and SLEEVE surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Heart of England NHS Foundation Trust, Birmingham, United Kingdom
Obesity is an increasing health problem in the UK and one which is predicted to worsen. It is associated with many health problems that can shorten a person's life span and impair quality of life. Current national guidelines recommend that surgery is considered for the very overweight (morbidly obese) or for those remaining obese after trying other options.
In the UK and worldwide the three most commonly performed operations are laparoscopic adjustable gastric banding ('BAND surgery'), laparoscopic gastric bypass ('BYPASS') and laparoscopic sleeve gastrectomy ('SLEEVE'). All lead to weight loss, but they are associated with different problems. In the short term there are varying complications and inconvenience relating to the operation. In the longer term there are different outcomes relating to weight regain, symptoms and side effects of surgery. This study (BYBANDSLEEVE) is a randomised trial with a recruitment target of 1341 patients in twelve hospitals and its aim is to compare the effectiveness, cost effectiveness and acceptability of BAND, BYPASS and SLEEVE surgery. The process of randomisation will mean that participants have a chance of receiving one of the three procedures, so a fair comparison between them can be made.
The first phase (in two hospitals) will test the feasibility of recruitment and optimise information for patients to maximise trial recruitment. It will establish a core set of clinical outcomes to use to evaluate the surgery for morbid obesity. The second stage (in 12 hospitals) will recruit the full sample and follow up all participants for at least three years. The investigators will compare the effects of BAND, BYPASS AND SLEEVE surgery three years after randomisation on weight loss, a wide range of symptoms and aspects of quality of life. The investigators will also examine patients' detailed experiences during follow up, nutritional outcomes, short and long term surgical complications and National Health Service (NHS) value for money.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical intervention in which a band is inserted around the top of the stomach to reduce its size.
Surgical intervention where a small pouch is made in the top of the stomach and a loop of bowel connected to this pouch to bypass the rest of the stomach.
Surgical intervention which reduces the size of the stomach by about 75%, creating a narrow tube. It is done by stapling down the stomach and removing the remainder of the stomach.
Time frame: Three years
The proportion achieving loss of greater than 50% of excess weight at three years (calculated as 100×[BMI at 3 years - BMI at randomisation1] / [BMI at randomisation - 25])
Time frame: Three years
HRQoL at three 3 years, will be assessed using the EQ-5D-5L
Time frame: Three years
Change in BMI over time adjusted for BMI at randomisation
Time frame: Three years
Percentage weight loss at 3 years
Time frame: Three years
Waist circumference at 3 years
Time frame: Three years
Time taken from randomisation to reach first loss of at least 50% of excess BMI
Time frame: Three years
Time taken from first losing 50% excess BMI to first relapse (defined as weight re-gain such that the target of at least 50% of excess weight loss is no longer met)
Time frame: Three years
Impact of Weight on Quality of Life (IWQOL-Lite)
Time frame: Three years
The Gastrointestinal Quality of Life Index
Time frame: Three years
Eating Habits Questionnaire
Time frame: Three years
SF-12v2 Health Survey
Time frame: Three years
Hospital Anxiety and Depression Scale (HADS).
Time frame: Three years
Use of health service resources over the three-year study period.
Time frame: Three years
Standard NHS nutritional blood tests will be performed at each assessment.
Time frame: Three years
Measures of 24 hour recall eating using a standardised and validated interview process
Time frame: Three years
Binge eating behaviour using a validated questionnaire
Time frame: Three years
Adverse health events including the need for re-operation and cross over between interventions
Time frame: Three years
Resolution of co-morbidities at 3 years, including sleep apnoea, non alcoholic fatty liver disease, type-2 diabetes, hypertension and hyperlipidaemia.
Time frame: Three years
Time to resolution of sleep apnoea, type-2 diabetes, hypertension and hyperlipidaemia
University of Bristol
Other
Gastric Bypass, Adjustable Gastric Banding or Sleeve Gastrectomy Surgery to Treat Severe and Complex Obesity: a Multi-centre Randomised Controlled Trial
Acronym: ByBandSleeve
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06541977
Behavior, Body Weight
View Trial DetailsNCT00687115
Body Weight, Body Weight Changes
Phoenix, Arizona, United States
View Trial DetailsNCT05184361
Body Weight, Body Weight Changes
Cruz Quebrada, Lisbon District, Portugal
View Trial DetailsNCT05540314
Body Weight, Body Weight Changes
Dallas, Texas, United States
View Trial Details